Navigation Links
Dasatinib, Nilotinib show strong early results as frontline therapy for chronic myelogenous leukemia
Date:12/9/2007

ATLANTA - Two drugs approved for use as second line therapy for chronic myelogenous leukemia are showing promising results as frontline therapy for newly diagnosed patients in two clinical trials, research teams led by scientists at The University of Texas M. D. Anderson Cancer Center report at the 49th annual meeting of the American Society of Hematology.

All patients in both trials have a complete cytogenetic response - absence of the aberrant chromosome that causes the disease - after one year on either drug. Approximately 90 percent reach complete cytogenetic response as early as 6 months.

"These are early results but certainly encouraging so far in both cases," says lead author Jorge Cortes, M.D., professor in M. D. Anderson's Department of Leukemia. Patients in both trials are in the chronic, or initial phase, of CML and had not received prior therapy for their disease.

The two medications are dasatinib, the Bristol-Myers Squibb drug known as Sprycel(r), and nilotinib, the Novartis drug known as Tasigna(r). Both have been approved by the U.S. Food and Drug Administration for use in CML patients whose disease becomes resistant to the frontline therapy imatinib, also a Novartis drug known as Gleevec(r), or who become intolerant to the drug.

Cortes and colleagues compared the two medications at 3, 6 and 12 months with historical data from patients who took either 400 mg or 800 mg daily of Gleevec.

For dasatinib, at three months 26 of 33 patients (79 percent) achieved complete cytogenetic response. At six months 30 of 32 (94 percent) and at 12 months all 24 evaluable patients were at a complete cytogenetic response.

For nilotinib, at three months 21 of 22 patients (95 percent) achieved complete cytogenetic response with all 13 evaluable patients at six months and all 11 at 12 months reaching complete cytogenetic response.

Historical complete cytogenetic responses for low-dose imatinib were 37
'/>"/>

Contact: Scott Merville
sdmervil@mdanderson.org
713-516-4855
University of Texas M. D. Anderson Cancer Center
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Smoking may strongly increase long-term risk of eye disease
2. Discovery suggests location of genes for breast density, a strong risk factor for breast cancer
3. Family History Has Strong Effect on Cardiac Risk
4. Allied Healthcare Reports Strong Fourth Quarter, Flat Net Income for Fiscal 2007 vs. 2006
5. New Jersey Physicians Launch New, Statewide Association to Fight for Stronger Voice in Healthcare
6. Dynatronics Announces Strong Fourth Quarter Profit
7. New Survey Finds Strong Public Interest in Prescription Drug Safety Issues
8. Audio: New Survey Finds Strong Public Interest in Prescription Drug Safety Issues
9. Armstrong Kids Get in Step with Good Health
10. Chubby Checker Adds Twist to 10,000 Strong at Ninth Annual Walk to Cure Cancer for UMass Memorial Cancer Center at the UMass Medical School
11. Produce for Better Health Foundation Releases Statement on Study Saying Fruit & Vegetable Consumption Not Strongly Associated With Colon Cancer Risk
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2014)... Representatives with Recharge Retreats ... list of destinations for International Yoga Teacher Trainings. , ... that the company chose Italy due to the fact ... trainings since it's an easy flight for Canadians and ... from all over Europe, UK, Africa, and the Middle ...
(Date:8/27/2014)... The Global and China Maleic Anhydride Industry ... state of the Maleic Anhydride industry in Global and ... the industry, including definitions, applications and industry chain structure. ... provided with a focus on history, developments, trends and ... international and Chinese situation is also offered. Get a ...
(Date:8/27/2014)... IQ Formulations , a leading manufacturer of ... of the Cystic Fibrosis Foundation. For an entire month ... led by TigerFitness.com in which 5 percent of the ... to the respected nonprofit organization. , Last year, ... Isla, a young girl fighting Cystic Fibrosis. The company ...
(Date:8/27/2014)... 27, 2014 Aspirus Wausau Hospital today ... US with Buzz™ Digital O.R. at Aspirus Wausau Hospital, ... 13 new operating rooms will be Buzz, a centralized ... integrative system supports planning, navigation, imaging and communications connectivity. ... of intuitive software and hardware all controlled from the ...
(Date:8/27/2014)... Salt Lake City, Utah (PRWEB) August 27, 2014 ... sponsorship of Wasatch Indoor Bike Park, Utah’s first indoor mountain ... an assortment of mountain and park-style bikes in both adult ... , SCOTT Sports, who already operated a distribution warehouse in ... Idaho, to Salt Lake City. , “We are proud to ...
Breaking Medicine News(10 mins):Health News:Recharge Retreats Adds Italy to Its International Yoga Teacher Trainings Destinations 2Health News:Recharge Retreats Adds Italy to Its International Yoga Teacher Trainings Destinations 3Health News:Maleic Anhydride Industry & Isoprene Market Global and China Analysis Now Available at ReportsnReports.com 2Health News:Maleic Anhydride Industry & Isoprene Market Global and China Analysis Now Available at ReportsnReports.com 3Health News:Maleic Anhydride Industry & Isoprene Market Global and China Analysis Now Available at ReportsnReports.com 4Health News:Maleic Anhydride Industry & Isoprene Market Global and China Analysis Now Available at ReportsnReports.com 5Health News:IQ Formulations Contributes Sizeable Donation to Cystic Fibrosis Foundation 2Health News:Aspirus Wausau Hospital Announces First Large Scale Digital Operating Room Integration Project in the US 2Health News:Aspirus Wausau Hospital Announces First Large Scale Digital Operating Room Integration Project in the US 3Health News:SCOTT Sports to Sponsor Wasatch Indoor Bike Park 2
... Inc. (OTC Bulletin Board: NZYM) today announced financial results for its ... , , For the fourth quarter ended March ... of $4.6 million for the same period last year. Gross ... income of $1.1 million for the same period last year. ...
... Health Care, Insurers Can "Discriminate...On the Basis of Which ... June 3 At a press conference today in ... Poizner to praise new rules proposed by the Department ... when they get sick. The group called on ...
... ... communication breakdowns that contribute to delays in care and clinical decision-making, Fauquier Hospital in ... 15-25 minutes per shift. , ... Knoxville, TN (PRWEB) June 3, 2009 -- In an effort to eliminate ...
... Informatics Solution enables healthcare professionals to more immediately ... information , , WARRENDALE, Pa., June 3 ... an informatics application that enables healthcare professionals to ... radiology patients, contrast injections from nearly anywhere. This ...
... USAID/State Department/Private Sector Initiative Unveils Initial Aid to ... and CAFAmerica,s Saxon-Harrold Report on Progress. , ... Woman Initiative ( http://www.OneWomanInitiative.org ), a one-year-old public/private ... Muslim populations, today announced its first grants, totaling ...
... release is available in French . , ... discovered that a widely used anti-diabetic drug can boost the ... treatments. Their findings will be published June 3 in the ... Dr. Russell Jones, an assistant professor at McGill,s Goodman Cancer ...
Cached Medicine News:Health News:Synthetech Announces Fiscal 2009 Results 2Health News:Synthetech Announces Fiscal 2009 Results 3Health News:Synthetech Announces Fiscal 2009 Results 4Health News:Synthetech Announces Fiscal 2009 Results 5Health News:Synthetech Announces Fiscal 2009 Results 6Health News:Consumer Watchdog Praises Insurance Commissioner Poizner for Health Insurance 'Rescission' Rules, Pans Schwarzenegger Administration for Failure to Regulate HMOs 2Health News:Consumer Watchdog Praises Insurance Commissioner Poizner for Health Insurance 'Rescission' Rules, Pans Schwarzenegger Administration for Failure to Regulate HMOs 3Health News:Fauquier Hospital Nurses Increasing Productivity by 15-25 Minutes per Shift with PerfectServe 2Health News:MEDRAD Introduces Manage.Report - Advances Evidence-Based Decision Making 2Health News:MEDRAD Introduces Manage.Report - Advances Evidence-Based Decision Making 3Health News:'One Woman Initiative' Announces First Grants to Women's Organizations in Five Nations 2Health News:'One Woman Initiative' Announces First Grants to Women's Organizations in Five Nations 3Health News:'One Woman Initiative' Announces First Grants to Women's Organizations in Five Nations 4Health News:Common diabetes drug may 'revolutionize' cancer therapies 2
(Date:8/27/2014)...  Columbia Laboratories, Inc. (Nasdaq: CBRX ) ... clinical trial manufacturing, and advanced analytical and consulting services ... participate at the upcoming Rodman & Renshaw 16 th ... New York . The Company will ... 2014 at the New York Palace Hotel. ...
(Date:8/27/2014)... LYNDHURST N.J. and NINGBO, China ... ("Amerigen") and the Ningbo Menovo Pharmaceutical Co., Ltd, ("Menovo") ... regarding the development of generic pharmaceuticals, primarily targeting ... terms of the agreement, Amerigen and Menovo will jointly ... the United States . Menovo will be responsible ...
(Date:8/27/2014)... ON , Aug. 27, 2014 /CNW/ - Covalon Technologies ... technologies company, announces the following financial results for its third ... ended June 30, 2014: , Revenue of $1,291,378, ... year , Net loss for the quarter of $240,156 ... of the prior year For the nine ...
Breaking Medicine Technology:Amerigen Pharmaceuticals Limited and the Ningbo Menovo Pharmaceutical Co., Ltd, today announced they had entered into a collaboration agreement regarding the development of generic pharmaceuticals, primarily targeting the United States market 2Covalon Announces Third Quarter Results 2Covalon Announces Third Quarter Results 3
... COVE, N.Y., Sept. 8 In response to the news ... issued a recall of its ASR product line after data ... five years after the initial procedure, Dr. Eugene S. Krauss, ... Orthopedic and Rehabilitation Institute at Glen Cove Hospital, a member ...
... the Indiana State Legislature,s Criminal Law and Sentencing Policy ... state can improve its policies for preventing the illegal ... leading cold and allergy medicines - for methamphetamine production. ... from requiring a prescription for currently accessible medicines like ...
Cached Medicine Technology:Patients Should Expect 'Long Life' from their Joint Replacements! 2Indiana State Legislators Seek Solutions to Combat Illegal Meth Production 2Indiana State Legislators Seek Solutions to Combat Illegal Meth Production 3
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: